GlassScriptPhysician profile
Hadi Hatoum
NPI 1891953378
$7,106.00
in general payments reported to CMS, 2019-2025
29 companies · $2,087 in 2025
The $2,087 reported for 2025 was more than what 87% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $511 · 2023: $1,027 · 2024: $3,482 · 2025: $2,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,582 · Education: $1,504 · Travel and Lodging: $1,494 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,581.58 |
| Education | $1,504.36 |
| Travel and Lodging | $1,494.26 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,080.56 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $619.63 | 2022-2025 | Tezspire, Tagrisso, Fasenra |
| Glaxosmithkline, LLC. | $481.47 | 2022-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $400.38 | 2022-2025 | Ofev |
| Grifols USA, LLC | $255.35 | 2023-2025 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $191.99 | 2022-2024 | Yupelri |
| Insmed, INC. | $157.98 | 2022-2025 | Arikayce, Brinsupri |
| Baxter Healthcare | $105.59 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Olympus America INC. | $88.63 | 2022-2025 | |
| Genzyme Corporation | $78.37 | 2024-2025 | |
| Harmony Biosciences LLC | $71.66 | 2024-2025 | |
| Viatris Specialty LLC | $68.50 | 2025 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $67.00 | 2022-2024 | Opsumit, Uptravi |
| Verona Pharma, INC. | $55.18 | 2025 | Ohtuvayre |
| Covis Pharma Gmbh | $50.79 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $45.10 | 2025 | Zepbound |
| Jazz Pharmaceuticals INC. | $35.12 | 2024 | |
| Coaptech, INC. | $32.88 | 2025 | Puma System |
| Abbvie INC. | $31.30 | 2023-2025 | |
| Amgen INC. | $26.34 | 2023 | Tezspire |
| Csl Behring | $24.30 | 2025 | Hizentra |
| Takeda Pharmaceuticals U.S.A., INC. | $22.20 | 2025 | Glassia |
| Genentech, INC. | $21.08 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $18.18 | 2025 | Dupixent |
| Merck Sharp & Dohme LLC | $17.70 | 2023 | |
| Electromed, INC. | $15.05 | 2023 | Smartvest |
| Tactile Systems Technology INC | $14.69 | 2024 | Entre Plus, Flexitouch Plus |
| Resmed Corp | $14.62 | 2025 | |
| La Jolla Pharmaceutical Company | $14.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hadi Hatoum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.